



Turmeric (Curcuma longa L.) products: What quality differences 
exist?
Chatzinasiou, L., Booker, A., MacLennan, E., Mackonochie, M. 
and Heinrich, M.
 
NOTICE: this is the authors’ version of a work that was accepted for publication in 
Journal of Herbal Medicine. Changes resulting from the publishing process, such as 
peer review, editing, corrections, structural formatting, and other quality control 
mechanisms may not be reflected in this document. Changes may have been made to 
this work since it was submitted for publication. A definitive version was subsequently 
published in Journal of Herbal Medicine, DOI: 10.1016/j.hermed.2019.100281, 2019.
The final definitive version in Journal of Herbal Medicine is available online at:
https://dx.doi.org/10.1016/j.hermed.2019.100281
© 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
https://creativecommons.org/licenses/by-nc-nd/4.0/
The WestminsterResearch online digital archive at the University of Westminster aims to make the 
research output of the University available to a wider audience. Copyright and Moral Rights remain 
with the authors and/or copyright owners.
Whilst further distribution of specific materials from within this archive is forbidden, you may freely 
distribute the URL of WestminsterResearch: ((http://westminsterresearch.wmin.ac.uk/).
In case of abuse or copyright appearing without permission e-mail repository@westminster.ac.uk
Turmeric (Curcuma longa L.) products: What quality differences exist?
Abstract
Background: Curcuma longa L. (root and rhizome), commonly known as turmeric, is 
a plant of high medicinal and economic value globally, including within the EU where 
it is mainly used as a food and food supplement. Its key active ingredients have been 
studied extensively, but concerns remain about the composition and thus the quality of 
extracts and products on the market. Recently, problems of adulteration with other 
Curcuma species and general poor quality have been detected within crude turmeric 
powders and final products. This study aimed to investigate the chemical variation of 
turmeric finished products available in the UK and identify the quality of turmeric 
products obtained from specific stages of the supply chain, with a focus on quality 
differences in the UK. 1H-NMR spectroscopy metabolomics coupled to Principle 
Component Analysis (PCA) and HPTLC methods were used for the phytochemical and 
metabolomics investigation of 72 turmeric samples, including crude powders, 
intermediate products from different manufacturing stages and commercial products 
obtained from health food stores and the Internet. A significant variation in the chemical 
composition of turmeric finished products, especially in the ones containing turmeric 
extracts, was found. Several products were found to contain only curcumin or 
curcuminoids, while the other active ingredients and marker compounds of C. longa 
were lacking. Products obtained from different stages of the Pukka value chain 
presented similar chemical composition, with the intermediate products (S57-59) 
showing the highest amount of active ingredients. Consequently, the manufacturing 
practices involved in the production of turmeric food supplements are critical stages to 
obtain high-quality final products. Often the focus has been only on the primary 
material, its natural variation and forms of production. This study highlights the 
importance of developing well-controlled integrated systems for the quality assurance 
of dietary supplements throughout the supply chain from seed to final product. 
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Introduction 
Curcuma longa L. (Zingiberaceae) root and rhizome, commonly known as turmeric, 
has a long history of medicinal and nutritional applications, especially in Asian 
countries. Over the past few years, its importance has been widely recognised globally, 
and, therefore, numerous studies have been published (Prasad and Aggarwal, 2011). 
A large variety of turmeric products are readily accessible via the internet or health 
food shops, mainly as food supplements, and these vary in formulation, concentration 
of supposed active substances, additional ingredients or recommended dosages. 
Successive studies have highlighted the inconsistent quality of Curcuma longa and 
Curcuma supplements as well as the variability of the active metabolites (Dixit et al., 
2009; Li et al., 2011; Starling, 2009). Booker et al (2014a) reported a wide range of 
curcuminoid content within UK sourced samples and a lack of important compounds 
typically found within the volatile oils, e.g. ar-turmerone (Booker et al., 2014a). This 
is partly due to a lack of consensus on the relative importance of different constituents 
relevant for its therapeutic benefits, and partly due to differing quality within the 
various markets. 
Although curcumin presents one of the most pharmacologically important constituents 
in turmeric, it is claimed that the low bioavailability restricts its clinical applications 
(Shishu, 2010). Several studies have shown that curcumin is barely absorbed by the 
gastrointestinal tract when ingested, due to rapid metabolic breakdown by the liver 
(Ammon et al., 1992; Anand et al., 2009; Li et al., 2011; Ravindranath and 
Chanfrasekhara, 1981; Wang et al., 1997). 
A common approach to attempt to enhance the oral bioavailability of curcumin is its 
combination with other natural compounds, such as piperine and ginger (Maharao et 
al., 2016). Piperine, the main active compound found in black and long peppers (Pipper 
nigrum L. and Piper longum L.), has been reported to inhibit the glucuronidation of 
many drugs, as well as improving curcumin bioavailability (Prasad et al., 2014). 
Therefore, a number of finished products on the market now contain piperine, or black 
or long pepper in attempt to make these products more attractive to consumers. 
However, other constituents in turmeric, such as the compounds found in the essential 
oils, and metabolites such as tetrahydro-curcuminoids, may play an important role, and 
there is increasing evidence to suggest a local effect of turmeric on the microbiome and 
local inflammation levels in the gut (Kukula-Koch et al., 2018; Santosh et al., 2017). 
Toden et al (2017) found that a combination of curcumin and turmeric essential oils 
had superior anti-inflammatory activity to curcumin alone in a mouse model of colitis. 
Additionally, a pilot human study of oral bioavailability of a range of turmeric 
formulations found that a combination of curcumin with essential oils had superior 
bioavailability to both curcumin alone and a combination of curcumin and piperine 
(Antony et al, 2008). Other studies, however, have found only minimal increases in 
relative absorption of curcuminoids with the addition of essential oils (Purpura et al, 
2017).
As further research is needs to determine the relative bioavailability and therapeutic 
benefits of different turmeric-derived formulations, it will be useful to have tools able 
to group preparations according to their active ingredients to compare with therapeutic 
benefits. 
In essence, this results in two distinct but related challenges: 
- The need to understand the composition of the turmeric materials which are 
commercialised
- The development of optimum preparations
Aims and objectives
In this paper we focus on the first of these two tasks. Therefore, the main scientific aims 
of this study were: 
• To understand the spectrum of bioactive constituents found within Pukka products 
and their concentration within the product using an approach combining NMR-
metabolomic analysis and HPTLC.
• To understand the supply chain by investigating the compositional differences 
among a range of dried powder and fresh turmeric powdered rhizome from India. 
• To examine the compositional diversity among finished turmeric products available 
in the UK.
• To identify any adulterants within these products. 
Materials and methods
Samples collection
72 samples were analysed in total. 50 finished turmeric products were purchased from 
stores mainly in Central London, but also Germany, the USA and from the Internet. 
The products were formulated in capsules (43), tablets (2), softgels (2), powder (1) and 
extracts (2) and they claimed to contain either plant extract or crude ground material of 
the plant or a combination of plant extract and crude ground material. 22 samples were 
provided by Pukka Herbs, including Wholistic Turmeric® products (6; S41-46), crude 
ground material from India (10), Pukka Turmeric Wholistic Extract (3; S57-59) and 
Pukka Turmeric Powder (3). The finished products were formulated into capsules and 
claimed to contain both plant extract and crude ground material of the plant.
Reference standards
Curcumin reference standard (mixture of three curcuminoids, Lot 69H3457) was 
obtained from Sigma-Aldrich, (S)-ar-Turmerone from LKT Laboratories (Lot 
2598838) and piperine standard form LKT Laboratories (Lot 2598684).
1H-NMR Spectroscopy
1H-NMR spectra of turmeric samples was measured on a Bruker Avance 500 MHz 
spectrophotometer (Bruker Analytik Rheinstetten, Germany) equipped with a 5mm 
cryoprobe head and operating at proton frequency of 500.13 MHz at temperature 298 
K. The acquisition parameters were: 0.16 Hz/ point, pulse width= 30° and relaxation 
delay= 1 s, 256 scans. TOPSPIN software version 3.2 was used for spectra acquisition 
and processing. Centrifuge (EppendorfTM MiniSpinTM, 1010813), ultrasonic bath 
(VWRTM, 110233) and analytical balance (METTLER TOLEDO, AB135-S/FACT) 
were also used for the sample preparation.
Sample preparation for 1H-NMR analysis
The method for the analysis of turmeric samples was based on a method used by Booker 
et al (2014a). DMSO-d6 was selected as extracting solvent, due to the increased amount 
of peaks present in 1H-NMR spectra in a previous study (Booker et al., 2014a). 
Approximately 20 mg of all the samples were weighted into a 1.5 ml reaction tube and 
1.0 ml of deuterated DMSO-d6 containing 0.05% TMS was added. 
The mixtures were shaken on a rotary mixer for 60 s, sonicated for 15 min at room 
temperature, and allowed to stand for 1 h. Then, the mixtures were centrifuged for 10 
min at 14,000 rpm and 600 μl of the supernatant was transferred to a 5mm diameter 
NMR spectroscopy tube.  The samples were submitted for NMR analysis. 
 
Principle Component Analysis (PCA)
TOPSPIN software version 3.2 was used to acquire and process the spectra. The spectra 
were acquired with 256 scans, requiring about 18 min acquisition time. The scans were 
locked at zero on the TMS peak. The residual solvent signal for DMSO was excluded. 
The samples, including commercial products, crude materials and standards, were 
numbered 1 to 75. Microsoft EXCEL was used for the analysis of the data. Sample 42 
was analysed twice (421, duplicate sample) as a control in order to check the robustness 
and reproducibility of both PCA and NMR. The data were imported to SIMCA version 
14.0 software for PCA analysis. 
HPTLC
The CAMAG HPTLC equipment was used, composed of Visualizer, Automatic TLC 
sampler 4 (ATS4) and TLC sampler LINOMAT 5, Automatic Developing Chamber 2 
(ADC2), Chromatogram Immersion Device III for derivatisation, TLC plate heater III 
and TLC scanner coupled to VisionCats version 1.4 software. Centrifuge (EppendorfTM 
MiniSpinTM, 1010813), ultrasonic bath (VWRTM, 110233) and analytical balance 
(METTLER TOLEDO, AB135-S/FACT) were also used for the sample preparation.
Sample preparation for HPTLC
The method for the analysis of turmeric samples was based on a method used by 
(Booker et al., 2014b). The method for the extraction of the samples was based on a 
standardized method used at CAMAG laboratories and Booker et al (2014a). Methanol 
was used for the determination of curcuminoids and toluene for the determination of 
essential oils. Two different developing systems were applied, one for curcuminoid 
determination (Toluene: acetic acid, 4:1) and another one for essential oils 
(Dichloromethane). About 200 mg of all samples were weighted into 10 ml reaction 
tubes and 4.0 ml of solvent was added. Two different solvents were tested: methanol 
for curcuminoid and dye adulterant determination and toluene for the determination of 
essential oils. The mixture was mixed using a rotary mixer for 60 s and sonicated for 
10 min. Then, the supernatant solution was transferred to a vial and was centrifuged for 
10 min at 14,000 rpm. The samples were submitted for HPTLC analysis.
HPTLC Analysis
HPTLC glass 20x10 cm, Si 60 F254 plates were loaded with the turmeric samples in 
the CAMAG Automatic TLC Sampler 4. Then 4 μl of each sample and standard were 
applied to the plate as 8 mm bands. The maximum number of samples per plate was 15. 
The plates were obtained from CAMAG Laboratories, Muttenz, Switzerland and 
developed using a CAMAG Automatic Development Chamber ADC 2 using two 
different mobile phases, toluene: acetic acid (4:1) for curcuminoid determination and 
dichloromethane for the determination of essential oils. The lab temperature was 23°C. 
The humidity of the tank was controlled at about 33%, after the treatment with 
magnesium chloride solution. After the development the plate was dried for 5 min and 
then heated at 100°C for 2 min, using a CAMAG automatic TLC heater. The plates 
were derivatised by dipping in anisaldehyde reagent for the detection of both 
curcuminoids and essential oils, using a CAMAG chromatogram immersion device III 
and heated to 100°C for 3 min on a plate heater. The plates were inspected using a 
CAMAG visualizer under white light and at UV 254 nm, after the development.  After 
the derivatisation, the plates were visualized under white light and UV 366 nm. The 
results were uploaded to the VisionCats version 1.4 software.
Results and discussion
1H-NMR spectroscopy coupled to PCA-metabolomics investigation  
Finished products
1H-NMR spectroscopy coupled to Principal Component Analysis (PCA) was used to 
investigate the variation in the chemical composition of turmeric products within 
different stages of the value chain. Samples (numbered as S1-S72) were crude materials 
from different suppliers (S63-72), processed turmeric powders (S60-62, manufacturing 
stage), extracted materials (S57-59, manufacturing stage) and finished commercial 
products (S1-56).  Visual inspection of the acquired NMR spectra shows that the 
variation between the samples is significant. Several samples presented similar spectra, 
while others showed almost undetectable quantities of Curcuma longa L. In order to 
compare the individual 1H-NMR spectra, curcumin, piperine and ar-turmerone 
standards were also analysed.
The samples were divided into groups, depending on their origin, use and 
form/preparation and were separated using PCA scores plot. Two different plots were 
created, one to compare the different turmeric finished products and one to investigate 
products obtained from four different stages of the Pukka value chain. In order to better 
understand the differences and similarities among turmeric samples, the region 
associated with the most characteristic peaks for curcuminoids, ar-turmerone and 
piperine (6-8 ppm) was selected for observation. 
Figure 1: Scores plot in the chemical shift region 6-8 ppm, comparing different turmeric finished 
products containing powdered material, extract or a combination of both. Food 
Supplement/Powder (FS/P), Food Supplement/ Extract (FS/E), Food Supplement/ Powder+ 
Extract (FS/P+E). Curcumin , piperine and ar-turmerone standards are also presented (CS, PS, 
TS). X axis: Principle Component 1 (PC1), Y axis: Principle Component 2 (PC2). (n=60)
The products composed only of turmeric powder were grouped together (yellow), while 
turmeric extracts showed important metabolite variability and no distinct clustering 
occurred (red) (Fig 1). Several of them were placed out of the score plot, indicating 
possible absence of C. longa constituents or adulteration with other Curcuma species. 
The significant variation in the distribution of turmeric extracts could be also attributed 
to the different extracting solvents used to formulate each product. However, the 
information related to their extraction process was not provided on the label, and, 
therefore, they could not be separated to smaller clusters. These results imply that the 
processing of the crude material is a significant but, in the herbal industries and by the 
general public, often ignored complex series of stages within the production of turmeric 
food supplements.
Finished products S41-46 appeared to be close to ar-turmerone and curcumin standards 
(S75 and S73 respectively), which shows that these samples were likely to be high in 
these constituents. Subsequent quantitative analysis confirmed that S41=46 were high 
in ar-turmerone, while their curcumin concentration was average (Fig 2 & 3).Sample 
21, containing the highest amount of piperine (20 mg according to the label), appeared 
very close to the piperine standard (S74), as expected (Fig 1). Samples 3, 33 and 14 
(extracts) appeared to be out of the scores plot, which indicates that they significantly 
differ from the other samples in the chemical shift region 6-8 ppm. Samples 3 and 33 
were very well grouped, signifying that they possibly had similar metabolic profiles. 
Subsequent HPTLC analysis showed that they were strong in curcumin and piperine, 
but did not contain any other active ingredient from C. longa, while sample 14 
contained only the three major curcuminoids and piperine. 
The quantitative evaluation of the samples was based on the average peak intensity they 
presented in three specific chemical shift regions associated with ar-turmerone (7.04- 
7.13 ppm), curcuminoids (6.73- 6.84 ppm) and piperine (6.851- 7.0 ppm). The samples 
were sorted in descending order, according to their average absorbance values in these 
regions, and, therefore, their concentration in ar-turmerone and piperine could be 
determined. The higher the peak intensity is in a specific region, the higher is the 
concentration of a specific compound or a group of compounds in the sample.
Ar-turmerone is an important active constituent of turmeric essential oil, which 
provides C. longa with its unique fragrance and has been found to increase the uptake 
of curcumin by human intestinal epithelial Caco-2 cells in vitro (Park et al., 2012). A 
combination of both sesquiterpenoids and curcuminoids had superior pharmacological 
effects in a mouse model of diabetes to extracts of either compound type alone 
(Nishiyama et al, 2005). Independently of curcumin, ar-turmerone has been found to 
have tumour inhibiting and anti-inflammatory activity (Aggarwal et al., 2013). This 
compound can only be detected in C. longa, while it is absent in C. aromatica and C. 




































Figure 2: Chart showing turmeric finished products (S1-S56) in descending order, according to 
their average peak intensity in the chemical shift region related to Ar-turmerone peak (7.04-7.13 




















Figure 3: Chart showing turmeric finished products (S1-S56) in descending order, according to 
their average peak intensity in the chemical shift region related to curcumin peak (6.73-6.84 ppm). 
Pukka products (S41-46) are highlighted in bright orange (see also Table 2).
In Fig. 2, ar-turmerone reference presented the higher average absorbance, as expected., 
S41-46 presented high average absorption values in the region related to ar-turmerone. 
Therefore, in these products the quantity of ar-turmerone appeared to be comparatively 
high. Sample 39 showed the highest average peak intensity among all samples, and, 
therefore, concentration in ar-turmerone.
S41-46 appeared to contain an average quantity of curcumin (Fig. 3). Although samples 
14, 3 and 33 were placed outside the scores plot (Fig. 1), they presented the highest 
amount of curcumin. Subsequent HPTLC analysis showed that samples 3 and 33 were 
not C. longa, as they were only composed of curcumin. However, sample 14 presented 
all bands related to curcuminoids.
Products from along the Pukka value chain
 Figure 4 shows several products obtained from four different stages of the Pukka value 
chain. Some samples were crude materials from different suppliers within the Pukka 
value chain (S63-72), others were products obtained from two different manufacturing 
stages within the production, including processed turmeric powders (S60-62) and 
extracted materials (S57-59), and finally several of them were finished commercial 
products (S41-46). Sample 42 was analysed twice in order to assess the reproducibility 
of the measurements, thus two spots are presented in the scores plot (S421, S422). 
Figure 4: Scores plot in the chemical shift region 6-8 ppm, comparing products from four different 
stages of the Pukka value chain: finished products (PUKKA), extracted materials (TWE/PUKKA), 
processed powders (TP/PUKKA) and crude materials from different suppliers (TP/DS). 
Curcumin, piperine and ar-turmerone standards are also presented (CS, PS, TS). X axis: Principle 
Component 1 (PC1). Y axis: Principle Component 2 (PC2). (n=25)
Pukka finished products (S41-46, orange colour) appeared to be somewhere between 
Wholistic extracts and turmeric powders, as they are composed of a combination of 
these two preparations (Fig 4). This suggests that the quality of the final products is 
strongly influenced by the quality and concentration of the intermediate products 
obtained from the different manufacturing processes.
Extracts S57-59 were presented near the ar-turmerone standard, indicating that the 
extraction process used probably improves the concentration in active ingredients, and 
especially ar-turmerone (Fig 4). Pukka Turmeric powders (S60-62) were grouped with 
the crude powders obtained from different suppliers, showing similar metabolite profile 
to the starting materials. 
As shown above, using NMR metabolomics, turmeric samples were successfully 
clustered into smaller groups based on their metabolite content. Samples containing 
turmeric powder were clearly separated from those containing turmeric extracts, 
indicating a variation in their chemical composition. In addition, the data obtained from 
NMR spectroscopy were effectively used for the quantitative analysis of the samples.  
However, this method was not able to provide information about why the clustering 
among turmeric products occurred. Furthermore, some samples containing botanicals 
other than C. longa, such as ginger (S39, 41-46) could not be differentiated from the 
rest of the samples. Finally, overlapping signals of different compounds or noise 
interference might also have occurred. Therefore, subsequent HPTLC analysis was 
performed to better understand the chemical composition of the samples. 
HPTLC analysis
72 turmeric samples both final products and crude materials were analysed using 
HPTLC. Two developing systems were used, one for the identification of curcuminoids 
and piperine and the other for the detection of essential oils. Curcumin, piperine and ar-
turmerone standards were run together with the samples, in order to identify the 
presence of these compounds in the samples.
In Fig. 5, curcuminoids and piperine standards are illustrated on the top and all the 
finished turmeric products at the bottom (S1-56). Curcumin is the top band (RF= 0.39), 
demethoxycurcumin the middle band (RF= 0.28) and bis-demethoxycurcumin the 
bottom band (RF= 0.18). Piperine standard was illustrated as a yellow band at higher 
RF value than curcuminoids (RF =0.46).
Figure 5: HPTLC plate under white light after derivatisation with anisaldehyde reagent, 
illustrating curcumin and piperine standards and samples 1-56, divided into groups (Group A: S3, 
33, Group B: S48, 49, 54, 55, 14, Group C: S25, 53, Group D: S6, 8, 36, 10, 11, 2, 12, 29, 31, 37, 51, 
56, 22, 23, 21, 18, 19, 26, 4, Group E: S17, 35, 39, 41-46, Group F: S47, 24, 20, 27, 28, 30, 32, 34, 38, 
40, 50, 52, 1, 5, 7, 9, 13, 15, 16). Mobile phase toluene-acetic acid 4:1 (identification of 
curcuminoids).
Group A samples, extracts standardised to 95% curcuminoids (S3, S33), showed two 
strong zones for curcumin and piperine (RF= 0.39 and 0.46 respectively), but they did 
not present any of the other bands associated with the other curcuminoids. This 
indicates that these samples are not C. longa, confirming the results obtained from the 
PCA analysis (Fig. 1). 
Group B extracts presented strong zones for all curcuminoids (Fig. 5). Among these 
samples, S14 was the only one showing a yellow band for piperine at RF =0.46. The 
absence of any other bands higher than the characteristic piperine band is probably due 
to the fact that these samples did not contain crude powder, but only an extract 
standardised to 95% curcuminoids.
Group C samples had an intense purple band at RF = 0.14, and two other bands at 
RF=0.52 and RF=0.61. These bands were also found in the fingerprints of the crude 
powders from different suppliers (see Appendix 4). Thus, this indicates that these 
samples were composed of crude turmeric rhizomes.
Group D samples exhibited the three characteristic zones for curcuminoids, a strong 
zone for piperine and two other zones, found also in C. longa crude powders, at RF=0.52 
and RF=0.61. As expected, S21 presented the strongest piperine band. Samples 51, 22, 
26 and 4 showed intense bands for all curcuminoids.
Group E samples had similar bands to Group D, but they also presented a faint extra 
band at RF=0.81. According to the HPTLC association C. longa samples should not 
show a purple zone at RF=0.81 and RF=0.57, as this could indicate adulteration with 
other Curcuma species. Sample 39 presented the strongest zone for this RF value 
(RF=0.81). This could have happened because S39 also contained ginger or due to 
adulteration with other Curcuma species. The yellow zone for piperine could not be 
clearly identified in samples S41-46, as their fingerprint at RF=0.4-0.5 was blurry. 
Sample 17 claimed to contain the Longvida® optimized extract. However, the extra 
zones present indicate that it may be adulterated with other species. Also, the other 
bands related to C. longa significantly differed from the rest of the samples at the RF 
values. 
Group F samples showed all bands known to represent curcuminoids, with samples 5 
and 47 presenting the strongest zones. Some of these samples claimed to contain 
piperine (S 5, 7, 9, 13, 20, 24, 28, 30, 34, 38), while others did not contain any piperine, 
such as samples 47, 1, 15, 16, 27, 32, 40, 50 and 52. Although some samples did not 
contain any piperine, they showed a pale pink band at RF =0.46 (piperine zone). 
In Fig. 6, the ar-turmerone standard is illustrated on the top (RF = 0.59). Group A 
extracts appeared to contain no or minimum amounts of ar-turmerone and other 
turmeric essential oils. This may have happened due to age, as the potency of volatile 
oils is lost over time (Turek   and Stintzing, 2013). Specifically, sample 3 showed only 
two zones at very low RF values, confirming that it was not C. longa (see also Fig. 5)
Figure 6: HPTLC plate under white light after derivatisation using anisaldehyde reagent, 
illustrating Ar-turmerone standard and samples 1-56, divided into groups (Group A: S3, 14, 54, 
55, 48, 59, Group B: S33, 35, 36, 20). Mobile phase dichloromethane (identification of essential 
oils).
Although, Group B samples contained ar-turmerone, they differed from the other 
samples, as they exhibited an extra zone at RF= 0.63. These samples also presented a 
faint zone at RF= 0.89, which was also present in the fresh rhizomes, according to 
Booker (2014). As confirmed by the HPTLC analysis of curcuminoids, sample 33 was 
not C. longa (Fig. 5).
S41-46 and sample 39 (Group C) presented the strongest zones for ar-turmerone and a 
very strong zone at RF=0.89, possibly because they were obtained from a shorter supply 
chain, and, therefore, they presumably were fresher. These samples also showed some 
extra bands at intermediate RF values (e.g. at RF= 0.1), probably due to the presence of 
other ingredients, such as ginger. 
All the other samples contained ar-turmerone and presented similar fingerprints. Their 
only difference was based on the band at RF= 0.89. Some samples did not produce this 
band, such as samples 23, 56, 52, 53, 50, 47 and 51 or presented a very pale zone (S21, 
26, 22, 18, 25 etc.), probably because they were older (Fig. 6). 
In Figure 7, Pukka finished (S41-46) and intermediate products (S57-62), as well as 
starting materials from different suppliers (S63-72) are illustrated. Curcuminoids 
standard (C) is also presented, with curcumin being the top band (RF= 0.39), 
demethoxycurcumin the middle band (RF= 0.28) and bis-demethoxycurcumin the 
bottom band (RF= 0.18). 
Figure 7: HPTLC plate under UV light (366 nm) after derivatisation with anisaldehyde reagent, 
illustrating Pukka finished (S41-46) and intermediate products (S57-62), curcumin standard (C) 
and crude turmeric powders (S63-72). Mobile phase toluene-acetic acid 4:1 (identification of 
curcuminoids).
All crude powders from different suppliers (S63-72) are C. longa, as they present all 
the bands related to curcuminoids. In addition, they showed two extra zones at higher 
RF values (RF=0.52 and RF=0.61), which were also presented in almost all finished 
turmeric products (see Fig. 5). Sample 65 showed the weakest zones for curcuminoids, 
while samples 69 and 71 the strongest ones among the crude materials. Pukka turmeric 
powders (S60-62) exhibited the same bands as crude turmeric powders and almost the 
same concentration. S57-59 on the other hand, showed the strongest zones for 
curcuminoids, indicating that the extraction process improves the concentration of key 
compounds.
All samples showed the characteristic band related to ar-turmerone at RF=0.59 (Figure 
8). S57-59 (Wholistic Extracts) presented the strongest bands among all samples. 
Finished products S41-46 also displayed a strong zone for ar-turmerone, stronger than 
Pukka turmeric powders (S60-62). This is because the final products were prepared 
using a combination of powder and extract. 
HPTLC is a low-cost and flexible technique that enables the detailed investigation of 
the chemical composition of multiple samples. As described above, using this method 
the compounds presented in turmeric samples were easily separated and observed 
visually. There were samples that did not contain all active ingredients of C. longa, 
illustrated by incomplete fingerprints, and others that contained additional ingredients 
or botanicals, and thus exhibited more complex fingerprints than expected. However, 
this method also involves some limitations, such as the low sensitivity and separation 
power. This explains the fact that several turmeric samples exhibited a band at RF =0.46, 
although they did not contain piperine as an ingredient. Therefore, the combination of 
the two analytical techniques, NMR metabolomics and HPTLC, was necessary to 
obtain valid and consistent results.
Conclusions 
In this study 1H-NMR metabolomics and HPTLC analytical techniques were applied to 
investigate the quality of commercial turmeric products available in the UK, as well as 
the chemical variation of turmeric products obtained from specific stages within the 
Pukka value chain, including starting materials, processed powders, extracted materials 
and end products. Both methods exhibited interesting, complementary data and it was 
possible to provide a qualitative and quantitative analysis of turmeric samples. 
Curcuminoids and turmeric essential oil components were the main medicinally 
important compounds analysed. The presence of piperine was also investigated within 
the samples, as this compound has been widely used in turmeric preparations, promoted 
for improving the bioavailability of curcumin.
Regarding the commercial products, the results showed that there was an important 
variation in the chemical composition of turmeric products, ranging in concentration 
and number of active ingredients. The products marketed as containing only turmeric 
powder presented a similar metabolite profile. However, important chemical variation 
appeared in the products composed of turmeric extracts or a combination of extracts 
and powder. Some extracts were found to contain only curcumin, while others did not 
contain any essential oils but did have the three basic curcuminoids. There were also 
several samples that contained ingredients additional to those from C. longa, such as 
ginger, which were expected according to their formulation claims. The variation 
among turmeric extracts indicates that the manufacturing practices, including the 
extraction process of the crude material, play a major role in the final product quality, 
requiring an integrated approach along the entire value chain of a product. S41-46 were 
shown to be among the turmeric products with the highest concentration of 
curcuminoids and particularly the essential oil components.
Some samples appeared to contain significant amounts of piperine, while others with 
such a label claim either had very small quantities, almost undetectable levels or no 
piperine. There were also samples that, although they did not contain any piperine as 
an ingredient, exhibited a pink band at RF =0.46.  
Turmeric products obtained from various stages of the Pukka value chain, presented 
similar metabolite variability and quality, typical for an integrated quality control 
system. All crude powders from different suppliers were C. longa. Processed powders 
appeared to have identical chemical composition to the crude biological materials. In 
addition, intermediate products S57–S59 exhibited significantly higher concentration 
in curcuminoids and ar-turmerone than the powders, indicating that the extraction 
process applied leads to enhanced quality extracts, and, therefore, improves end product 
quality. 
Until there is consensus about which constituents and additives are most important to 
harness the anti-inflammatory benefits of turmeric, the composition of different 
products will continue to vary widely. The great variety in products leads to difficulty 
in comparing the different products available and in interpreting clinical trials and other 
research into the effects of turmeric. Future research is needed to ascertain the relative 
importance of different constituents and any synergy that may happen between them.
This study has focused on C. longa, which is one of the most popular species within 
the genus of Curcuma. Since its popularity continuously increases and these products 
become more accessible to consumers, it is very important that commercial products 
are of acceptable quality and safety. 
Overall, this study shows that high value-added plant-based products can be produced 
using carefully controlled processing steps throughout the value chain. Specific EU 
standards and more stringent regulations need to be designed and implemented for 
dietary supplements, to further guarantee the products’ quality and safety. 
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